Bausch Health Companies Inc. saw its stock rise 40% after reporting Q2 non-GAAP EPS of $1.26, beating expectations by $0.25, with 13% revenue growth and improved margins and cash flow. The company also raised its full-year 2026 guidance, signaling confidence in its operational momentum. However, significant risks remain due to its $15 billion long-term debt and $800 million interest expense in the first half of the year, which keep credit ratings speculative and analysts cautious. Investors should weigh strong financial performance against these balance sheet challenges moving forward.
Bitcoin closed the week down 2.7% at around $62,990, with spot Bitcoin ETFs reversing strong inflows into outflows and XRP briefly falling below $1 due to a cross-chain bridge exploit. Despite stable prices, significant structural shifts occurred: Go...
Bitcoin is currently exhibiting a rare long-term oversold condition on two key technical indicators, suggesting the bearish trend may be nearing exhaustion. Analyst Katie Stockton highlights this alongside improving momentum, which could indicate the...
Bitcoin saw increased inflows to major exchanges like Binance, Kraken, and Bitstamp even as its price threatened to drop below $62,000. This rise in exchange reserves suggests growing selling potential, which could suppress any short-term price recov...
Anthropic has introduced a subtle watermarking system for its Claude AI-generated text, triggering a surge in demand for apps that claim to remove these watermarks. These watermarks use complex statistical word patterns, making them hard to detect or...
Charles Hoskinson has introduced Anthropies, a tool designed to remove hidden watermarks and metadata from content generated by the AI model Claude. Anthropies targets Claude's keyed text watermark, C2PA image credentials, and Git commit trailers tha...
